M. Kathleen Behrens
CIK: 0001211701
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (14 total)
- Jun 4, 2026SRPT
Sarepta Therapeutics, Inc.
Award(A)Direct16.9K shares- - Jan 27, 2026SRPT
Sarepta Therapeutics, Inc.
Exercise(M)Direct10.5K shares at avg. $13.71$144K - Jan 27, 2026SRPT
Sarepta Therapeutics, Inc.
Tax Payment(F)Direct6.5K shares at avg. $22.17$144K - Aug 14, 2025IGMS
IGM Biosciences, Inc.
Disposition(D)Indirect330.7K shares- - Aug 14, 2025IGMS
IGM Biosciences, Inc.
Disposition(D)Indirect29.8K shares- - Aug 14, 2025IGMS
IGM Biosciences, Inc.
Disposition(D)Indirect29.8K shares- - Aug 14, 2025IGMS
IGM Biosciences, Inc.
Disposition(D)Direct22.2K shares- - Jun 30, 2025IGMS
IGM Biosciences, Inc.
Award(A)Direct1.5K shares- - Jun 18, 2025MDXG
MIMEDX GROUP, INC.
Award(A)Direct28.6K shares at avg. $6.47$185K - Mar 31, 2025IGMS
IGM Biosciences, Inc.
Award(A)Direct1.5K shares- - Mar 10, 2025SRPT
Sarepta Therapeutics, Inc.
Award(A)Direct2.4K shares- - Dec 31, 2024IGMS
IGM Biosciences, Inc.
Award(A)Direct3.1K shares- - Sep 30, 2024IGMS
IGM Biosciences, Inc.
Award(A)Direct3.1K shares- - Sep 4, 2024SRPT
Sarepta Therapeutics, Inc.
Gift(G)Direct746 shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 4, 2026 |  SRPT Sarepta Therapeutics, Inc. | Award(A) | 16,875 | - | $0 | Direct |
| Jan 27, 2026 | SRPT Sarepta Therapeutics, Inc. | Exercise(M) | 10,500 | $13.71 | $143,955 | Direct |
| Jan 27, 2026 | SRPT Sarepta Therapeutics, Inc. | Tax Payment(F) | 6,494 | $22.17 | $143,972 | Direct |
| Aug 14, 2025 |  IGMS IGM Biosciences, Inc. | Disposition(D) | 330,700 | - | - | Indirect |
| Aug 14, 2025 | IGMS IGM Biosciences, Inc. | Disposition(D) | 29,807 | - | - | Indirect |
| Aug 14, 2025 | IGMS IGM Biosciences, Inc. | Disposition(D) | 29,806 | - | - | Indirect |
| Aug 14, 2025 | IGMS IGM Biosciences, Inc. | Disposition(D) | 22,222 | - | - | Direct |
| Jun 30, 2025 | IGMS IGM Biosciences, Inc. | Award(A) | 1,471 | - | - | Direct |
| Jun 18, 2025 |  MDXG MIMEDX GROUP, INC. | Award(A) | 28,609 | $6.47 | $185,100 | Direct |
| Mar 31, 2025 | IGMS IGM Biosciences, Inc. | Award(A) | 1,471 | - | - | Direct |
| Mar 10, 2025 | SRPT Sarepta Therapeutics, Inc. | Award(A) | 2,383 | - | - | Direct |
| Dec 31, 2024 | IGMS IGM Biosciences, Inc. | Award(A) | 3,078 | - | $0 | Direct |
| Sep 30, 2024 | IGMS IGM Biosciences, Inc. | Award(A) | 3,078 | - | $0 | Direct |
| Sep 4, 2024 | SRPT Sarepta Therapeutics, Inc. | Gift(G) | 746 | - | $0 | Direct |
1-14 of 14 transactions
About BEHRENS M KATHLEEN
BEHRENS M KATHLEEN (SEC CIK 0001211701) files insider reports with the SEC as Director of Sarepta Therapeutics, Inc. (SRPT), Director of IGM Biosciences, Inc. (IGMS) and Director of MIMEDX GROUP, INC. (MDXG).
Signal8 holds 10 ownership filings by BEHRENS M KATHLEEN, all Form 4s, filed between Sep 5, 2024 and Jun 5, 2026. Those filings report 14 transactions, from Sep 4, 2024 to Jun 4, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on BEHRENS M KATHLEEN's filings is in CAMBRIDGE, MA.
Recent filings by BEHRENS M KATHLEEN
- Jun 4, 2026: Grant or award of SRPT shares (Form 4, code A).
- Jan 27, 2026: Option exercise of SRPT shares (Form 4, code M).
- Jan 27, 2026: Tax withholding of SRPT shares (Form 4, code F).
- Aug 14, 2025: Disposition to issuer transactions of IGMS shares (4 lines, Form 4, code D).
- Jun 30, 2025: Grant or award of IGMS shares (Form 4, code A).
Other insiders filing for Sarepta Therapeutics, Inc. (SRPT)
- Wong Ryan Ho-Yan, Chief Financial Officer
- Estepan Ian Michael, Chief Operating Officer
- Rothfuss Cristin, EVP, General Counsel
- Rodino-Klapac Louise, President, R&D and Tech Ops
- SEVERINO MICHAEL, Chief Executive Officer
- Boor Kathryn Jean, Director